Clinical Trials in Anyang-si, Gyeonggi-do

9 recruiting

Showing 19 of 9 trials

Recruiting
Phase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled194 locationsNCT07190222
Recruiting
Phase 4

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease
Sanofi218 enrolled58 locationsNCT07053423
Recruiting

Asciminib RMP Study

Chronic Myeloid Leukemia
Novartis Pharmaceuticals600 enrolled17 locationsNCT05943522
Recruiting
Phase 1

Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis

Lupus Nephritis (LN)
Regeneron Pharmaceuticals90 enrolled11 locationsNCT06975787
Recruiting
Phase 3

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Primary Sjogrens Disease
argenx580 enrolled304 locationsNCT06684847
Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc.3,000 enrolled141 locationsNCT01522183
Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Parkinson Disease
Glaceum90 enrolled9 locationsNCT06329141
Recruiting
Not Applicable

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Seoul National University Hospital340 enrolled9 locationsNCT06618638
Recruiting
Phase 2

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
Korea Institute of Oriental Medicine70 enrolled7 locationsNCT06249854